E B Nguyen1,2, E A Jacobs1, K M Summers1, A E Sparks1, B J Van Voorhis1, V E Klenov1, E H Duran3,4. 1. Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Iowa Hospitals and Clinics, Iowa City, IA, 52242, USA. 2. Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, 98195, USA. 3. Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Iowa Hospitals and Clinics, Iowa City, IA, 52242, USA. hakan-duran@uiowa.edu. 4. Department of Obstetrics and Gynecology, 200 Hawkins Drive, 31322 PFP, Iowa City, IA, 52242, USA. hakan-duran@uiowa.edu.
Abstract
PURPOSE: This study aims to know what proportion of culture day 5 pre-blastocyst-stage embryos develop into blastocysts by culture day 6 and what patient and cycle characteristics are associated with delayed blastocyst formation. METHODS: A retrospective observational cohort analysis was performed including a total of 9886 embryos from 1008 IVF cycles in 835 patients, who underwent treatment between January 1, 2016, and December 31, 2018. Autologous fresh in vitro fertilization (IVF) cycles at a single academic center were included in the analysis. Embryos were group-cultured using single-step culture media. Blastulation was defined as the presence of a new blastocyst. Usable blastulation was defined as the presence of a new good or excellent quality, expanded, hatching, or hatched blastocysts. RESULTS: The mean blastulation rate between days 5 and 6 of extended embryo culture was 30.9%. The mean percentage of embryos developing into usable blastocyst-stage embryos was 19.8%. The factors associated with blastulation on day 6 included the total number of embryos and the number of pre-blastocysts on day 5, as well as the use of ICSI. Age, the number of total embryos, those remained in culture and pre-blastocysts, as well as the blastulation rate on day 5 were associated with usable blastulation. CONCLUSION: It is important to know the usable blastocyst development rate between culture days 5 and 6 in order to adequately counsel patients debating whether to proceed with fresh ET on day 5 or forego ET with the expectation that embryos will be biopsied for PGT and/or cryopreserved on culture day 6. Our findings provide evidence to help guide patients in this difficult decision.
PURPOSE: This study aims to know what proportion of culture day 5 pre-blastocyst-stage embryos develop into blastocysts by culture day 6 and what patient and cycle characteristics are associated with delayed blastocyst formation. METHODS: A retrospective observational cohort analysis was performed including a total of 9886 embryos from 1008 IVF cycles in 835 patients, who underwent treatment between January 1, 2016, and December 31, 2018. Autologous fresh in vitro fertilization (IVF) cycles at a single academic center were included in the analysis. Embryos were group-cultured using single-step culture media. Blastulation was defined as the presence of a new blastocyst. Usable blastulation was defined as the presence of a new good or excellent quality, expanded, hatching, or hatched blastocysts. RESULTS: The mean blastulation rate between days 5 and 6 of extended embryo culture was 30.9%. The mean percentage of embryos developing into usable blastocyst-stage embryos was 19.8%. The factors associated with blastulation on day 6 included the total number of embryos and the number of pre-blastocysts on day 5, as well as the use of ICSI. Age, the number of total embryos, those remained in culture and pre-blastocysts, as well as the blastulation rate on day 5 were associated with usable blastulation. CONCLUSION: It is important to know the usable blastocyst development rate between culture days 5 and 6 in order to adequately counsel patients debating whether to proceed with fresh ET on day 5 or forego ET with the expectation that embryos will be biopsied for PGT and/or cryopreserved on culture day 6. Our findings provide evidence to help guide patients in this difficult decision.
Authors: Diana H Wu; Kasey Reynolds; Rose Maxwell; Steven R Lindheim; Mira Aubuchon; Michael A Thomas Journal: Fertil Steril Date: 2011-06-08 Impact factor: 7.329
Authors: Ioannis A Sfontouris; Wellington P Martins; Carolina O Nastri; Iara G R Viana; Paula A Navarro; Nick Raine-Fenning; Sheryl van der Poel; Laura Rienzi; Catherine Racowsky Journal: J Assist Reprod Genet Date: 2016-08-05 Impact factor: 3.412
Authors: Danilo Cimadomo; C Scarica; R Maggiulli; G Orlando; D Soscia; L Albricci; S Romano; F Sanges; F M Ubaldi; L Rienzi Journal: J Assist Reprod Genet Date: 2018-05-03 Impact factor: 3.412
Authors: Jonathan D Kort; Ruth B Lathi; Kathleen Brookfield; Valerie L Baker; Qianying Zhao; Barry R Behr Journal: J Assist Reprod Genet Date: 2015-04-29 Impact factor: 3.412
Authors: Jigal Haas; Jim Meriano; Rawad Bassil; Eran Barzilay; Eran Zilberberg; Robert F Casper Journal: Fertil Steril Date: 2018-11-12 Impact factor: 7.329